EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity

Wanting Jiang, Shudan Yin, Lingmin Li, Menghao Teng iD

PLOS One · 29.08.2025 · 20 (8) · e0331444

DOI: 10.1371/journal.pone.0331444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 29.08.2025. Verfasst von Wanting Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Imaging, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Definity significantly enhances the diagnostic accuracy of echocardiography but raises ongoing safety concerns. This study aimed to explore potential adverse events (AEs) associated with Definity in real-world settings by analyzing data from the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).

Methods

We retrospectively extracted AE reports from the FAERS database between 2004 and the first quarter of 2024. Disproportionality analyses using reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and multi-item gamma Poisson shrinker (MGPS) were conducted to identify signals potentially associated with Definity. Univariate and multivariate logistic regression analyses were performed as sensitivity analyses to assess potential risk factors for Definity-related AEs.

Results

A total of 4460 reports with Definity as the “primary suspected” drug were included. We identified 104 statistically significant signals at PT level, including common AEs such as back pain and muscle spasms, as well as exploratory signals not listed on the drug label, such as eye movement disorder and renal pain. It is noteworthy that 21 signals did not retain significance following Bonferroni correction. These AEs spanned 25 System Organ Classes (SOCs). In reports with available time-to-onset data, most events occurred within 30 days of administration, while some were reported at longer intervals. Moreover, logistic regression analysis indicated that both gender and body weight were independent risk factors associated with Definity-related AE.

Conclusion

This study provides exploratory insights into potential AEs associated with Definity based on real-world pharmacovigilance data. While most signals are consistent with known safety profiles, several emerging signals warrant further investigation and clinical awareness. These findings may contribute to ongoing risk management and pharmacovigilance efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHumansUnited States Food and Drug AdministrationUnited StatesMaleFemaleRetrospective StudiesMiddle AgedAgedAdultDatabases, FactualRisk FactorsBayes TheoremAdolescentYoung Adult

Autor:innen und Institutionen

  • Department of Ultrasound Imaging, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shaanxi, China.
  • Department of Sports Medicine and Joint Surgery, Xi'an Ninth Hospital), Xi'an, Shaanxi, China.

ORCID-Profile: Menghao Teng

Förderung

  • Key Research and Development Program of Shaanxi

Zitieren

APA

Jiang, W., Yin, S., Li, L., & Teng, M. (2025). A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity. PLOS One, 20(8), e0331444. https://doi.org/10.1371/journal.pone.0331444

Vancouver

Jiang W, Yin S, Li L, Teng M. A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity. PLOS One. 2025;20(8):e0331444. doi:10.1371/journal.pone.0331444

BibTeX
@article{Jiang2025,
  author = {Jiang, Wanting and Yin, Shudan and Li, Lingmin and Teng, Menghao},
  title = {A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {8},
  pages = {e0331444},
  doi = {10.1371/journal.pone.0331444}
}
Kostenlos starten →